Free Trial

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare logo
$196.40 +3.88 (+2.02%)
As of 09/5/2025 03:58 PM Eastern

Tenet Healthcare - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
4
Buy
15

Based on 19 Wall Street analysts who have issued ratings for Tenet Healthcare in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 4 have given a hold rating, 14 have given a buy rating, and 1 has given a strong buy rating for THC.

Consensus Price Target

$192.69
-1.89% Downside
According to the 19 analysts' twelve-month price targets for Tenet Healthcare, the average price target is $192.69. The highest price target for THC is $238.00, while the lowest price target for THC is $154.00. The average price target represents a forecasted downside of -1.89% from the current price of $196.40.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for THC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Tenet Healthcare and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THC Analyst Ratings Over Time

TypeCurrent Forecast
9/7/24 to 9/7/25
1 Month Ago
8/8/24 to 8/8/25
3 Months Ago
6/9/24 to 6/9/25
1 Year Ago
9/8/23 to 9/7/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
14 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$192.69$191.56$182.24$152.69
Forecasted Upside-1.89% Downside15.61% Upside9.62% Upside-0.46% Downside
Consensus RatingModerate BuyModerate BuyModerate BuyBuy

THC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

THC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Tenet Healthcare Stock vs. The Competition

TypeTenet HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.84
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-1.89% Downside16,047.34% Upside10.35% Upside
News Sentiment Rating
Positive News

See Recent THC News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/26/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Sarah James
Sarah James
Not Rated
Reiterated RatingOverweight$190.00+5.47%
8/14/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Stephen Baxter
Stephen Baxter
4 of 5 stars
Boost TargetOverweight$195.00 ➝ $200.00+17.35%
8/4/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Benjamin Rossi
Benjamin Rossi
Not Rated
Boost TargetOverweight$190.00 ➝ $200.00+23.94%
7/28/2025Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformPeer Perform
7/25/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetNeutral$195.00 ➝ $167.00+12.85%
7/24/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$215.00 ➝ $208.00+31.87%
7/23/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$230.00 ➝ $238.00+50.89%
7/23/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$185.00 ➝ $200.00+26.37%
7/23/2025Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$180.00 ➝ $188.00+20.48%
7/16/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$190.00 ➝ $205.00+19.53%
7/11/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$184.00 ➝ $194.00+11.11%
6/9/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$175.00 ➝ $210.00+28.10%
6/2/2025Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
5/14/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$165.00 ➝ $180.00+12.70%
5/5/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$134.00 ➝ $154.00+2.89%
4/30/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$183.00 ➝ $189.00+34.22%
4/15/2025Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
2/26/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$175.00+36.45%
1/7/2025KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$200.00 ➝ $185.00+44.25%
7/25/2024Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$139.00 ➝ $171.00+14.37%
6/28/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$150.00 ➝ $155.00+16.40%
11/14/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$95.00 ➝ $85.00+45.40%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:54 PM ET.


THC Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Tenet Healthcare is $192.69, with a high forecast of $238.00 and a low forecast of $154.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There are currently 4 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" THC shares.

According to analysts, Tenet Healthcare's stock has a predicted downside of -1.89% based on their 12-month stock forecasts.

Over the previous 90 days, Tenet Healthcare's stock had 1 downgrade by analysts.

Analysts like Tenet Healthcare more than other "medical" companies. The consensus rating score for Tenet Healthcare is 2.84 while the average consensus rating score for "medical" companies is 2.78. Learn more on how THC compares to other companies.


This page (NYSE:THC) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners